144 related articles for article (PubMed ID: 15989601)
1. Valaciclovir: development, clinical utility and potential.
Patel R
Expert Opin Investig Drugs; 1997 Feb; 6(2):173-89. PubMed ID: 15989601
[TBL] [Abstract][Full Text] [Related]
2. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Ormrod D; Scott LJ; Perry CM
Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
[TBL] [Abstract][Full Text] [Related]
3. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
4. Valaciclovir: a review of its use in the management of herpes zoster.
Ormrod D; Goa K
Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
[TBL] [Abstract][Full Text] [Related]
5. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.
Bodsworth NJ; Crooks RJ; Borelli S; Vejlsgaard G; Paavonen J; Worm AM; Uexkull N; Esmann J; Strand A; Ingamells AJ; Gibb A
Genitourin Med; 1997 Apr; 73(2):110-6. PubMed ID: 9215092
[TBL] [Abstract][Full Text] [Related]
6. [Valaciclovir].
Lebrun-Vignes B
Ann Dermatol Venereol; 2002 May; 129(5 Pt 1):708-15. PubMed ID: 12124513
[TBL] [Abstract][Full Text] [Related]
7. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
Johnston C; Saracino M; Kuntz S; Magaret A; Selke S; Huang ML; Schiffer JT; Koelle DM; Corey L; Wald A
Lancet; 2012 Feb; 379(9816):641-7. PubMed ID: 22225814
[TBL] [Abstract][Full Text] [Related]
8. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Wagstaff AJ; Faulds D; Goa KL
Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
[TBL] [Abstract][Full Text] [Related]
9. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
Patel R; Bodsworth NJ; Woolley P; Peters B; Vejlsgaard G; Saari S; Gibb A; Robinson J
Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091
[TBL] [Abstract][Full Text] [Related]
10. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy of acute herpes zoster in older patients.
Herne K; Cirelli R; Lee P; Tyring SK
Drugs Aging; 1996 Feb; 8(2):97-112. PubMed ID: 8845591
[TBL] [Abstract][Full Text] [Related]
12. Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.
Conant MA; Schacker TW; Murphy RL; Gold J; Crutchfield LT; Crooks RJ;
Int J STD AIDS; 2002 Jan; 13(1):12-21. PubMed ID: 11802924
[TBL] [Abstract][Full Text] [Related]
13. Valaciclovir: new indications. In genital herpes: simpler administration.
Prescrire Int; 1999 Feb; 8(39):8-9. PubMed ID: 10557565
[TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.
Keller MJ; Malone AM; Carpenter CA; Lo Y; Huang M; Corey L; Willis R; Nguyen C; Kennedy S; Gunawardana M; Guerrero D; Moss JA; Baum MM; Smith TJ; Herold BC
J Antimicrob Chemother; 2012 Aug; 67(8):2005-12. PubMed ID: 22556381
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus.
Colin J; Prisant O; Cochener B; Lescale O; Rolland B; Hoang-Xuan T
Ophthalmology; 2000 Aug; 107(8):1507-11. PubMed ID: 10919899
[TBL] [Abstract][Full Text] [Related]
17. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
[TBL] [Abstract][Full Text] [Related]
18. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group.
Reitano M; Tyring S; Lang W; Thoming C; Worm AM; Borelli S; Chambers LO; Robinson JM; Corey L
J Infect Dis; 1998 Sep; 178(3):603-10. PubMed ID: 9728526
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA).
Decroix J; Partsch H; Gonzalez R; Mobacken H; Goh CL; Walsh L; Shukla S; Naisbett B
J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):23-33. PubMed ID: 10877249
[TBL] [Abstract][Full Text] [Related]
20. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.
Fife KH; Barbarash RA; Rudolph T; Degregorio B; Roth R
Sex Transm Dis; 1997 Sep; 24(8):481-6. PubMed ID: 9293612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
